Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
November 10 is World Keratoconus Day, and five optometrists are raising awareness about a condition that remains largely unknown to the public. From FDA-approved epithelium-on corneal cross-linking to advanced scleral lenses, the message is clear: catching keratoconus early — especially in kids — can preserve vision and quality of life before it's too late.
November 10 marks World Keratoconus Day, and five leading optometrists are using the occasion to spotlight a condition that quietly robs patients — often teenagers — of their vision and confidence. Keratoconus, a progressive corneal disorder, remains largely unknown to the general public, yet its ripple effects extend well beyond the eye, impacting patients' independence, mental well-being, and entire family units.
The treatment landscape has transformed dramatically. Where gas-permeable lenses and corneal transplants were once the only options, clinicians now have access to advanced diagnostic imaging, FDA-approved epithelium-on corneal cross-linking, corneal tissue addition technology, and a wide range of specialty contact lenses — tools that can halt progression and restore near-normal vision when deployed early.
Key Takeaways:
Why it matters: Keratoconus is underdiagnosed and underrecognized, even within the broader medical community. With modern tools now available, timely intervention can mean the difference between a patient thriving — or losing functional vision entirely.
